Assaying of Tumor Necrosis Factor α, Complement Factors, and α-1-Antitrypsin in the Diagnosis of Malignant Serous Effusions

Michael G. Alexandrakis(University of Crete), George D. Eliopoulos(University of Crete), Rea Alexandraki(The General Hospital of Heraklion "Venizeleio-Pananio"), Ioannis G. Vlachonikolis(University of Oxford), Ioannis E. Κoutroubakis(University of Crete), Despina Kyriakou(University of Crete)
American Journal of Clinical Oncology
December 1, 2001
10.1097/00000421-200112000-00006
Cited by 7

Related Papers

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2
|Nature Genetics|2003|389
Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti–tumor necrosis factor-α antibody therapy
|Blood|2002|266
Ischemic colitis: Clinical practice in diagnosis and treatment
|World Journal of Gastroenterology|2008|264
Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study
|The American Journal of Gastroenterology|2016|203
Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease
|Inflammatory Bowel Diseases|2015|172